Mylan N.V. (NASDAQ: MYL) today announced the launch of the authorized generic for EpiPen (epinephrine injection, USP) Auto-Injector at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE